Discussion  by unknown
In conclusion, the MFP can be performed with low early
mortality in properly selected adult patients with functional
single ventricle. Early mortality is more likely with complex
lesions. Late survival is good and similar to results reported
in children. The majority of late survivors enjoy a good
quality of life.
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Discussion
Dr T. Spray (Philadelphia, Pa). I compliment the authors of
this excellent paper on their presentation of a large series of adult
patients who underwent Fontan reconstruction for variations of
single-ventricle anatomy over a 28-year period in a single institu-
tion. The authors have shown very nicely that the Fontan operation
can be performed in adult patients with excellent outcomes and
improvement in functional status, with mortality and complication
rates that are only slightly higher than those seen in the pediatric
population. Obviously, patient selection has much to do with the
excellent outcomes presented and therefore I have several ques-
tions for the authors.
Patients who came to the Fontan completion in this series had
class 3 or class 4 symptoms. I assume that most patients had
symptoms primarily related to progressive cyanosis rather than
heart failure. There have been some centers that have recom-
mended leaving patients with a Glenn anastomosis and not pro-
ceeding to a Fontan completion operation, especially in adults.
Your data would suggest that these patients eventually become
cyanotic enough to require a Fontan completion. Could you com-
ment on your institutional philosophy regarding the timing of and
indications for the completion operation in adult patients?
It is particularly interesting to note that in the series presented,
the majority of patients underwent atrial pulmonary operations and
relatively fewer adults had the lateral tunnel modification. Only 3
patients in the series underwent an extracardiac completion oper-
ation, even though this approach has been preferred in many
centers for as long as 10 years and would seem to be ideally suited
for those patients who had a previous Glenn anastomosis. Could
you comment on why the extracardiac approach has not been used
more commonly in your patient population? Is the lateral tunnel
technique still the preferred operation at the Mayo Clinic?
Prolonged pleural effusions greater than 2 weeks in duration
were noted in about 30% of the adult population that you pre-
sented. Fenestration of the Fontan baffle, however, was only uti-
lized in 2 patients in the series, and yet if cyanosis was the primary
indication for operation, a fenestration would still have permitted
improvement in oxygen saturation postoperatively and would
likely have limited the duration and severity of postoperative
effusions.
In your manuscript, which you kindly provided for me prior to
this discussion, it was noted that fenestration was used in patients
with mild elevation in pulmonary resistance or mildly decreased
ejection fraction. Could you elaborate more on what is considered
mild elevation of pulmonary resistance or a decrease in ventricular
function, considering that the significant majority of your patients
had a functional single left ventricle? Would patients with right
ventricular morphology have different indications for the complete
Fontan operation in your institution in adulthood, and would
fenestrations be more commonly used in that patient population?
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I also thought it was interesting to note the incidence of
arrhythmias both early and late postoperatively in your experience,
and I wonder whether you would use antiarrhythmic operations at
the time of completion Fontan more routinely now after having
this experience?
Dr Burkhart. Thank you, Dr Spray. With regard to our phi-
losophy concerning the timing of and indications for completion of
the modified Fontan operation in adult patients, the principal
indication was progressive decrease in exercise tolerance and
quality of life. Most patients (85%) were in NYHA functional class
III or IV. Objective progressive decline in ventricular function,
decline in arterial oxygen saturation, or increase in atrioventricular
valve regurgitation were other factors that were considered. Se-
lected deteriorating patients who were recognized to be at in-
creased risk for operation and for whom no other surgical options
were available were offered operation if it was thought there was
a reasonable chance for their survival and improvement, and some
such patients had excellent late results. However, we often still
find it difficult to determine with confidence which adult patients
who exceed accepted criteria for operability might be benefited by
a modified Fontan procedure and which should not be offered
operation. Elevated pulmonary arteriolar resistance and severe
systolic and diastolic ventricular dysfunction have been found to
be the most important contraindications to the modified Fontan
procedure. In general, the indications and criteria employed for
adults in this series were the same as for children at our institution.
With regard to which modifications of the Fontan procedure we
have used, your observation is correct that the majority of patients
at the beginning of our experience had an atriopulmonary connec-
tion without a lateral tunnel. Subsequently, both total cavopulmo-
nary connections and atriopulmonary connections with lateral tun-
nel were in vogue, as well as a few intracardiac and extracardiac
conduits. The latter modifications are still being performed, de-
pending on the cardiac anatomy and the individual surgeon’s
preference (there is no institutional philosophy in this regard). We
do have some reservations regarding the late fate of extracardiac
venous conduits, based on our experience that extracardiac con-
duits in the pulmonary ventricle–to–pulmonary artery position are
known to have a high incidence of late complications, especially
stenosis.
With regard to the role of atrial fenestrations, many of our
patients in this series were operated on prior to the introduction of
the fenestration concept. However, we remain relatively conser-
vative in the use of fenestrations, and do not employ them rou-
tinely with the hope they will avoid prolonged pleural effusions.
Fenestrations are applied selectively for patients with findings
which the attending cardiologist and surgeon anticipate will in-
crease the probability for postoperative morbidity or mortality,
especially if hemodynamics are borderline at the conclusion of the
modified Fontan procedure. If a fenestration is performed in an
adult patient, warfarin anticoagulation is usually recommended.
The long-term risks associated with chronic right-to-left shunting,
thrombus formation, and potential paradoxical embolism have
been of concern. In addition, there is a decrease in exercise
tolerance, and consequently quality of life, in fenestrated patients
with arterial desaturation.
With regard to the incidence of early and late atrial arrhyth-
mias, newer modifications such as the extracardiac conduit mod-
ified Fontan procedure, which has fewer atrial suture lines as well
as decreased atrial wall tension, may reduce the incidence of
postoperative arrhythmias. Use of a lateral tunnel baffle in which
suture lines avoid the crista terminalis may also reduce the inci-
dence of atrial arrhythmias. Late follow-up on large numbers of
patients will be necessary to demonstrate which of the many
Fontan procedure modifications will give the lowest incidence of
this important complication. Many different types of late atrial
arrhythmias have been noted in these patients, and the type of any
surgical antiarrhythmic operation performed depends on the spe-
cific type and mechanism of the arrhythmia. Additionally, any
surgical blocking lines or lines created by cryothermia or radio-
frequency have the potential for creating new re-entry arrhythmias.
Accordingly, we do not favor any prophylactic antiarrhythmic
procedures at the time of completion Fontan.
Dr D. Drinkwater (Nashville, Tenn). I very much enjoyed this
wonderful series spanning the decades, and I just have a couple of
questions. One is: Why in this series did you not have any Potts or
Waterston patients, or did I just miss that in your presentation? It
seemed as though most or all of your patients had modified Glenn
or Blalock-Taussig shunts. The majority of our adult single-ven-
tricle patients, unfortunately, have come to us with virtually dis-
continuous pulmonary arteries due to previous Potts or Waterston
shunts. Another large group of patients are those with prior classic
Glenn shunt and divergent pulmonary arteries. How did you uni-
focalize them? Did you use homograft or pericardial material? Do
you have any tricks that you could offer to us besides the extra-
cardiac, which seems to lend itself to this challenging group? I
look forward to reading your manuscript. Again, I very much
enjoyed your paper. Thank you.
Dr Burkhart. Thank you, Dr Drinkwater. Although the vast
majority of prior palliative procedures were the Blalock-Taussig
shunt and the Glenn shunt, there were also a number of patients
who previously had a central shunt. The Waterston shunt had been
performed in 19 patients and the Potts shunt had been performed
in 16 patients. Dr Puga can make additional comments about tricks
that we have learned in the operating room for patients who had
discontinuous pulmonary arteries.
Dr Puga. I will just comment on the techniques. Very rarely
did we operate on patients with nonconfluent pulmonary arteries,
but when it happens, we prefer to use a bifurcated pulmonary
homograft to reconstruct the pulmonary arterial confluence.
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